GTC’s posters from the 2025 Convention of the American Society of Clinical Oncology are now available for download. Please reach out with any questions.
Genomic Testing Cooperative and its founder and CEO, Dr. Maher Albitar, were recently featured in the Houston Business Journal in a “Face to Face” profile highlighting
Let’s meet at EHA2026, where we connect the global hematology community. EHA2026 will once again offer an exceptional scientific program, featuring a seamless flow of
Session: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia Defining APOBEC-like signature in diffuse large B-cell lymphoma and demonstration of distinct transcriptomic profile. Presenter: Adam Albitar, MD
New central U.S. location strengthens testing capacity and turnaround times while positioning GTC within the Texas Medical Center ecosystem HOUSTON — March 12, 2026 — Genomic
Lake Forest, CA — December 2, 2025 — Genomic Testing Cooperative (GTC), a leading provider of integrated DNA and RNA next-generation sequencing (NGS) solutions for
